Evidence map›Paper›PMID 41807582›Full record

ArticleCommunications biology2026

Physical exercise protects against Toxoplasma gondii infection-induced muscle atrophy and microvascular rarefaction.

Paloma de Carvalho Vieira, Carolina Epifânio, Samuel Iwao Horita, Karine Lino Rodrigues, Evelyn Pereira, Anissa Daliry, Leonardo Leal de Castro, Barbara Gomes da Rosa, Seth Kahn, Cynthia Machado Cascabulho and 4 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paloma de Carvalho VieiraLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-5858-8271
Carolina EpifânioLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0009-0002-3102-5836
Samuel Iwao HoritaLaboratório de Inovações em Terapias, Ensino e Bioprodutos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-2800-4746
Karine Lino RodriguesLaboratório de Fisiopatologia Clínica e Experimental, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Evelyn PereiraLaboratório de Fisiopatologia Clínica e Experimental, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-5511-7036
Anissa DaliryLaboratório de Fisiopatologia Clínica e Experimental, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Leonardo Leal de CastroLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Barbara Gomes da RosaLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Seth KahnLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0009-0006-2287-5037
Cynthia Machado CascabulhoLaboratório de Inovações em Terapias, Ensino e Bioprodutos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Mariana G ChauvetInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Mychael V LourencoInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-1078-0296
Helene Santos BarbosaLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Daniel AdesseLaboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil. adesse@ioc.fiocruz.br.ORCID http://orcid.org/0000-0002-7421-9510

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro) E-26/010-001199/2015Fundação Oswaldo Cruz (Oswaldo Cruz Foundation) 3231984391Fundação Oswaldo Cruz (Oswaldo Cruz Foundation) IOC-008-FIO-23
6 · The paper itself

Abstract

Toxoplasmosis is a leading cause of death from foodborne illness. Its causative agent, Toxoplasma gondii, forms cysts in skeletal muscle, contributing to parasite persistence and transmission. Cases of myositis have been reported in T. gondii-infected immunocompetent individuals, and impaired myogenesis has been demonstrated in mice. Herein we investigated the effects of T. gondii infection on glycolytic tibialis anterior (TA) and oxidative soleus (SOL) muscles in mice, and whether prior physical exercise could prevent infection-induced myopathology. Functional, metabolic, histological, inflammatory and microvascular parameters were analyzed 10 and 40 days post infection (dpi). T. gondii caused greater disruption to TA than to SOL, with increased atrophy and pathology. Expression of muscle atrophy-related genes (Atrogenes), including MURF1 and Atrogin-1, was strongly induced at 10 and normalized by 40 dpi. A fiber-type shift was observed in SOL at 40 dpi. Infected sedentary mice showed reduced grip strength and VO₂, while these effects were prevented by exercise. Exercised-infected mice had lower expression of Murf1, IL-6ra, STAT3, and pro/anti-inflammatory cytokine ratios compared to sedentary-infected controls. Exercise also preserved muscle and brain microvascular flow and prevented leukocyte-endothelium interactions. In conclusion, T. gondii differentially affects glycolytic and oxidative muscles; exercise protects muscle and brain against parasite-related damage.

Indexed as

MicrovesselsMuscle, SkeletalMuscular AtrophyPhysical Conditioning, AnimalToxoplasmaToxoplasmosisToxoplasmosis, AnimalAnimalsMaleMiceMice, Inbred C57BL

Identifiers

PMID41807582
PMCPMC13103317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.